- Home
- VOXR vs MYO Comparison
VOXR vs MYO Comparison
Compare VOXR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOXR
- MYO
- Stock Information
- Founded
- VOXR 2014
- MYO 2004
- Country
- VOXR United States
- MYO United States
- Employees
- VOXR N/A
- MYO N/A
- Industry
- VOXR Precious Metals
- MYO Industrial Specialties
- Sector
- VOXR Basic Materials
- MYO Health Care
- Exchange
- VOXR Nasdaq
- MYO Nasdaq
- Market Cap
- VOXR 168.0M
- MYO 153.0M
- IPO Year
- VOXR N/A
- MYO 2017
- Fundamental
- Price
- VOXR $3.23
- MYO $1.99
- Analyst Decision
- VOXR
- MYO Strong Buy
- Analyst Count
- VOXR 0
- MYO 4
- Target Price
- VOXR N/A
- MYO $9.13
- AVG Volume (30 Days)
- VOXR 860.4K
- MYO 793.8K
- Earning Date
- VOXR 08-06-2025
- MYO 08-05-2025
- Dividend Yield
- VOXR 1.53%
- MYO N/A
- EPS Growth
- VOXR N/A
- MYO N/A
- EPS
- VOXR N/A
- MYO N/A
- Revenue
- VOXR $10,845,445.00
- MYO $38,628,624.00
- Revenue This Year
- VOXR $16.51
- MYO $55.29
- Revenue Next Year
- VOXR $4.60
- MYO $27.18
- P/E Ratio
- VOXR N/A
- MYO N/A
- Revenue Growth
- VOXR N/A
- MYO 97.60
- 52 Week Low
- VOXR $2.21
- MYO $1.85
- 52 Week High
- VOXR $3.79
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- VOXR 46.91
- MYO 32.52
- Support Level
- VOXR $3.13
- MYO $1.85
- Resistance Level
- VOXR $3.39
- MYO $2.09
- Average True Range (ATR)
- VOXR 0.14
- MYO 0.14
- MACD
- VOXR 0.00
- MYO 0.04
- Stochastic Oscillator
- VOXR 48.72
- MYO 38.32
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).